Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety—A Narrative Review

CM Jîtcă, G Jîtcă, BE Ősz, A Pușcaș, S Imre - Pharmaceutics, 2023 - mdpi.com
The development of safe and effective pediatric formulations is essential, especially in
therapeutic areas such as pediatric cardiology, where the treatment requires multiple dosing …

Compounded nonsterile preparations and FDA-approved commercially available liquid products for children: A North American update

RH Parrish, LD Ashworth, R Löbenberg, S Benavides… - Pharmaceutics, 2022 - mdpi.com
The purpose of this work was to evaluate the suitability of recent US Food and Drug
Administration (US-FDA)-approved and marketed oral liquid, powder, or granule products …

Extemporaneous Compounding: Prevalence, Risks and Quality Assurance

S Vugigi - African Journal of Pharmacy and Alternative …, 2023 - journals.mjmbiolabs.co.ke
Extemporaneously compounded products are designed for an individual patient based on a
licensed physician's prescription in response to an identified need. Compounding provides …

[PDF][PDF] PA, 19134, USA.

RHP II, LD Ashworth, R Löbenberg, S Benavides… - 2022 - researchgate.net
The purpose of this work was to evaluate the suitability of recent US Food and Drug
Administration (USFDA) approved and marketed oral liquid, powder, or granule products for …